Login / Signup
Gülsel Yurtdaş-Kırımlıoğlu
(Gülsel Yurtdaş Kirimlioğlu)
ORCID
Publication Activity (10 Years)
Years Active: 2020-2021
Publications (10 Years): 4
Top Topics
Staphylococcus Aureus
Ionic Liquid
Drug Delivery
Cancer Therapy
Top Venues
Drug development and industrial pharmacy
Turkish journal of pharmaceutical sciences
Pharmaceutical development and technology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Gülsel Yurtdaş-Kırımlıoğlu
Spray dried nanospheres for inclusion complexes of cefpodoxime proxetil with β-cyclodextrin, 2-hydroxypopyl-β-cyclodextrin and methyl-β-cyclodextrin: improved dissolution and enhanced antibacterial activity.
Drug development and industrial pharmacy
(2021)
Gülsel Yurtdaş-Kırımlıoğlu
Development and characterization of lyophilized cefpodoxime proxetil-Pluronic® F127/polyvinylpyrrolidone K30 solid dispersions with improved dissolution and enhanced antibacterial activity.
Pharmaceutical development and technology
26 (4) (2021)
Gülsel Yurtdaş-Kırımlıoğlu
,
A Alper Öztürk
Levocetirizine Dihydrochloride-Loaded Chitosan Nanoparticles: Formulation and In Vitro Evaluation.
Turkish journal of pharmaceutical sciences
17 (1) (2020)
Gülsel Yurtdaş-Kırımlıoğlu
,
Şennur Görgülü
,
Murat Sami Berkman
Novel approaches to cancer therapy with ibuprofen-loaded Eudragit® RS 100 and/or octadecylamine-modified PLGA nanoparticles by assessment of their effects on apoptosis.
Drug development and industrial pharmacy
46 (7) (2020)